{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:47:48Z","timestamp":1794433668655,"version":"4.9.1"},"reference-count":29,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2019,12,26]]},"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To perform a systematic review and meta-analysis of maternal\/fetal outcomes in pregnant women with moderate\/severe native valvular heart disease (VHD) from medium\/higher Human Development Index (HDI) countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>OvidSP platform databases were searched (1985-January 2019) to identify studies reporting pregnancy outcomes in women with moderate\/severe VHD. The primary maternal outcome was maternal mortality. The primary fetal\/neonatal outcome was stillbirth and neonatal death. Pooled incidences and 95%\u2009confidence intervals (CI) of maternal\/fetal outcomes could only be calculated from studies involving mitral stenosis (MS) or aortic stenosis (AS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twelve studies on 646 pregnancies were included. Pregnant women with severe MS had mortality rates of 3% (95% CI, 0% to 6%), pulmonary oedema 37% (23%\u201351%) and new\/recurrent arrhythmias 16% (1%\u201325%). Their stillbirth, neonatal death and preterm birth rates were 4% (1%\u20137%), 2% (0%\u20134%), and 18% (7%\u201329%), respectively. Women with moderate MS had mortality rates of 1%(0%\u20132%), pulmonary oedema 18% (2%\u201333%), new\/recurrent arrhythmias 5% (1%\u20139%), stillbirth 2% (1%\u20134%) and preterm birth 10%(2%\u201317%).<\/jats:p>\n                    <jats:p>Pregnant women with severe AS had a risk of mortality of 2% (0%\u20135%), pulmonary oedema 9% (2%\u201315%), and new\/recurrent arrhythmias 4% (0%\u20137%). Their stillbirth, neonatal death and preterm birth rates were 2% (0%\u20135%), 3% (0%\u20136%) and 14%(4%\u201324%), respectively. No maternal\/neonatal deaths were reported in moderate AS, however women experienced pulmonary oedema (8%; 0%\u201320%), new\/recurrent arrhythmias (2%; 0%\u20135%), and preterm birth (13%; 6%\u201320%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Women with moderate\/severe MS and AS are at risk for adverse maternal and fetal\/neonatal outcomes. They should receive preconception counseling and pregnancy care by teams with pregnancy and heart disease experience.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2019-315859","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T17:25:15Z","timestamp":1581614715000},"page":"512-519","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":56,"title":["Pregnancy outcomes in women with significant valve disease: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1356-1646","authenticated-orcid":false,"given":"Robin Alexandra","family":"Ducas","sequence":"first","affiliation":[{"name":"Section of Cardiology, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Javier","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4049-2017","authenticated-orcid":false,"given":"Rohan","family":"D\u2019Souza","sequence":"additional","affiliation":[{"name":"Division of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice K","family":"Silversides","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Cardiology, University of Toronto Pregnancy and Heart Disease Program, Mount Sinai Hospital and Univeristy Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2356-4805","authenticated-orcid":false,"given":"Wendy","family":"Tsang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"2025100702353169000_106.7.512.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.085"},{"key":"2025100702353169000_106.7.512.2","unstructured":"PROSPERO . Maternal and fetal outcomes in pregnancy complicated by native left sided maternal valvular heart disease. UK: University of York: Centre for Reviews and Dissemination, 2016."},{"key":"2025100702353169000_106.7.512.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2025100702353169000_106.7.512.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2025100702353169000_106.7.512.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.03.134"},{"key":"2025100702353169000_106.7.512.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00340-0"},{"key":"2025100702353169000_106.7.512.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.07.750"},{"key":"2025100702353169000_106.7.512.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2008.11.029"},{"key":"2025100702353169000_106.7.512.9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of echocardiography developed in collaboration with the Society for cardiovascular magnetic resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"2025100702353169000_106.7.512.10","unstructured":"Wells G , Shea B , O'Connel D , et al . The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hosptial Research Institute, 2014."},{"key":"2025100702353169000_106.7.512.11","unstructured":"OpenMeta[Analyst]."},{"key":"2025100702353169000_106.7.512.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(11)90661-9"},{"key":"2025100702353169000_106.7.512.13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/0002-9378(85)90544-7","article-title":"Labor and delivery in the presence of mitral stenosis: central hemodynamic observations","volume":"152","author":"Clark","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"2025100702353169000_106.7.512.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb10395.x"},{"key":"2025100702353169000_106.7.512.15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5543\/tkda.2013.03295","article-title":"Clinical and echocardiographic follow-up in pregnant patients with valvular heart disease","volume":"41","author":"G\u00fcmr\u00fck\u00e7\u00fco\u011flu","year":"2013","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2025100702353169000_106.7.512.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01198-0"},{"key":"2025100702353169000_106.7.512.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2003.03.017"},{"key":"2025100702353169000_106.7.512.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00339-4"},{"key":"2025100702353169000_106.7.512.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijoa.2009.02.019"},{"key":"2025100702353169000_106.7.512.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032561"},{"key":"2025100702353169000_106.7.512.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"2025100702353169000_106.7.512.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31470-2"},{"key":"2025100702353169000_106.7.512.23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009395","article-title":"Neonatal and maternal outcomes in pregnant women with cardiac disease","volume":"7","author":"Owens","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2025100702353169000_106.7.512.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1029"},{"key":"2025100702353169000_106.7.512.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000031"},{"key":"2025100702353169000_106.7.512.26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5603\/KP.2019.0049","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy","volume":"77","author":"Regitz-Zagrosek","year":"2019","journal-title":"Kardiol Pol"},{"key":"2025100702353169000_106.7.512.27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.002810"},{"key":"2025100702353169000_106.7.512.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01020-X"},{"key":"2025100702353169000_106.7.512.29","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10 Suppl 1","author":"Blencowe","year":"2013","journal-title":"Reprod Health"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2019-315859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:35:42Z","timestamp":1759829742000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2019-315859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,3,13]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1136\/heartjnl-2019-315859"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2019-315859","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]}}}